Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3'-kinase/AKT signaling.

Insulin-like growth factor-1 (IGF-I) is a growth and survival factor in human multiple myeloma (MM) cells. Here we examine the effect of IGF-I on MM cell adhesion and migration, and define the role of beta1 integrin in these processes. IGF-I increases adhesion of MM.1S and OPM6 MM cells to fibronectin (FN) in a time- and dose-dependent manner, as a consequence of IGF-IR activation. Conversely, blocking anti-beta1 integrin monoclonal antibody, RGD peptide, and cytochalasin D inhibit IGF-I-induced cell adhesion to FN. IGF-I rapidly and transiently induces association of IGF-IR and beta1 integrin, with phosphorylation of IGF-IR, IRS-1, and p85(PI3-K). IGF-I also triggers phosphorylation of AKT and ERK significantly. Both IGF-IR and beta1 integrin colocalize to lipid rafts on the plasma membrane after IGF-I stimulation. In addition, IGF-I triggers polymerization of F-actin, induces phosphorylation of p125(FAK) and paxillin, and enhances beta1 integrin interaction with these focal adhesion proteins. Importantly, using pharmacological inhibitors of phosphatidylinositol 3'-kinase (PI3-K) (LY294002 and wortmannin) and extracellular signal-regulated kinase (PD98059), we demonstrate that IGF-I-induced MM cell adhesion to FN is achieved only when PI3-K/AKT is activated. IGF-I induces a 1.7-2.2 (MM.1S) and 2-2.5-fold (OPM6) increase in migration, whereas blocking anti-IGF-I and anti-beta1 integrin monoclonal antibodies, PI3-K inhibitors, as well as cytochalasin D abrogate IGF-I-induced MM cell transmigration. Finally, IGF-I induces adhesion of CD138+ patient MM cells. Therefore, these studies suggest a role for IGF-I in trafficking and localization of MM cells in the bone marrow microenvironment. Moreover, they define the functional association of IGF-IR and beta1 integrin in mediating MM cell homing, providing the preclinical rationale for novel treatment strategies targeting IGF-I/IGF-IR in MM.

[1]  N. Munshi,et al.  CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase/AKT/NF-kappa B signaling. , 2003, Blood.

[2]  G. Morgan,et al.  Essential Role of Caveolae in Interleukin-6- and Insulin-like Growth Factor I-triggered Akt-1-mediated Survival of Multiple Myeloma Cells* , 2003, The Journal of Biological Chemistry.

[3]  D. Hoessli,et al.  Anti-CD20 therapeutic antibody rituximab modifies the functional organization of rafts/microdomains of B lymphoma cells. , 2003, Cancer research.

[4]  A. Waage,et al.  Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor. , 2002, Blood.

[5]  C. Lacombe,et al.  Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma , 2002, Oncogene.

[6]  Masaharu Akiyama,et al.  Activation of NF-κB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications , 2002, Oncogene.

[7]  C. Martínez-A,et al.  Specific SHP-2 partitioning in raft domains triggers integrin-mediated signaling via Rho activation , 2002, The Journal of cell biology.

[8]  Weiqun Li,et al.  RACK1, an Insulin-Like Growth Factor I (IGF-I) Receptor-Interacting Protein, Modulates IGF-I-Dependent Integrin Signaling and Promotes Cell Spreading and Contact with Extracellular Matrix , 2002, Molecular and Cellular Biology.

[9]  L. Maile,et al.  Insulin-like Growth Factor I Increases (cid:1) V (cid:2) 3 Affinity by Increasing the Amount of Integrin-associated Protein That Is Associated with Non-raft Domains of the Cellular Membrane* , 2002 .

[10]  Kenneth C. Anderson,et al.  Vascular Endothelial Growth Factor-induced Migration of Multiple Myeloma Cells Is Associated with β1 Integrin- and Phosphatidylinositol 3-Kinase-dependent PKCα Activation* , 2002, The Journal of Biological Chemistry.

[11]  C. Martínez-A,et al.  Membrane raft microdomains in chemokine receptor function. , 2001, Seminars in immunology.

[12]  M. Hemler,et al.  Evaluation of Prototype Transmembrane 4 Superfamily Protein Complexes and Their Relation to Lipid Rafts* , 2001, The Journal of Biological Chemistry.

[13]  A. Lichtenstein,et al.  The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. , 2000, Cancer research.

[14]  G. Burns,et al.  The Integrins α3β1and α6β1Physically and Functionally Associate with CD36 in Human Melanoma Cells: REQUIREMENT FOR THE EXTRACELLULAR DOMAIN OF CD36 , 2000 .

[15]  S. Rudikoff,et al.  Insulin-like growth factor I is a dual effector of multiple myeloma cell growth. , 2000, Blood.

[16]  Y. Matsuzawa,et al.  Cytokines prevent dexamethasone-induced apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in a new multiple myeloma cell line. , 2000, Cancer research.

[17]  K. Vanderkerken,et al.  In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells. , 2000, Cancer research.

[18]  G. Bishop,et al.  Recruitment of CD40 and Tumor Necrosis Factor Receptor-associated Factors 2 and 3 to Membrane Microdomains during CD40 Signaling* , 2000, The Journal of Biological Chemistry.

[19]  A. Skubitz,et al.  CD63 associates with CD11/CD18 in large detergent‐resistant complexes after translocation to the cell surface in human neutrophils 1 , 2000, FEBS letters.

[20]  S. Naito,et al.  Calcitriol Therapy Modulates the Cellular Immune Responses in Hemodialysis Patients , 2000, American Journal of Nephrology.

[21]  A. Masumoto,et al.  β1 Integrins Play an Essential Role in Adhesion and Invasion of Pancreatic Carcinoma Cells , 2000 .

[22]  P. W. Janes,et al.  The role of lipid rafts in T cell antigen receptor (TCR) signalling. , 2000, Seminars in immunology.

[23]  B. Smedsrød,et al.  Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse , 2000, British Journal of Cancer.

[24]  W. Dalton,et al.  Integrin-Mediated Drug Resistance in Multiple Myeloma , 2000, Leukemia & lymphoma.

[25]  P. Altevogt,et al.  Integrin Leukocyte Function-associated Antigen-1-mediated Cell Binding Can Be Activated by Clustering of Membrane Rafts* , 1999, The Journal of Biological Chemistry.

[26]  C. Martínez-A,et al.  Membrane raft microdomains mediate front–rear polarity in migrating cells , 1999, The EMBO journal.

[27]  P. W. Janes,et al.  Aggregation of Lipid Rafts Accompanies Signaling via the T Cell Antigen Receptor , 1999, The Journal of cell biology.

[28]  M. Shakibaei,et al.  Signal transduction by β1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor , 1999 .

[29]  W. Dalton,et al.  Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell Lines , 1999 .

[30]  E. Rozengurt,et al.  Insulin-like growth factor I stimulates tyrosine phosphorylation of p130(Cas), focal adhesion kinase, and paxillin. Role of phosphatidylinositol 3'-kinase and formation of a p130(Cas).Crk complex. , 1998, The Journal of biological chemistry.

[31]  R. Klemke,et al.  Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo. , 1997, The Journal of clinical investigation.

[32]  P. Georgii‐Hemming,et al.  Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines. , 1996, Blood.

[33]  D. Clemmons,et al.  Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  E. Hirsch,et al.  Impaired migration but not differentiation of haematopoietic stem cells in the absence of β1 integrins , 1996, Nature.

[35]  M E Doerr,et al.  The Roles of Integrins and Extracellular Matrix Proteins in the Insulin-like Growth Factor I-stimulated Chemotaxis of Human Breast Cancer Cells (*) , 1996, The Journal of Biological Chemistry.

[36]  M. Urashima,et al.  Regulation of interleukin 6 in multiple myeloma and bone marrow stromal cells. , 1995, Stem cells.

[37]  T. Yednock,et al.  Mechanisms of β 1 integrin‐dependent adherence of granulocytic HL60 to fibronectin , 1995, Journal of leukocyte biology.

[38]  R. V. van Oers,et al.  Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. , 1994, Blood.

[39]  K. Anderson,et al.  Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. , 1993, Blood.

[40]  F. Braet,et al.  Insulin-like growth factor-1 acts as a chemoattractant factor for 5T2 multiple myeloma cells. , 1999, Blood.

[41]  M. Pierschbacher,et al.  Concept and progress in the development of RGD‐containing peptide pharmaceuticals , 1995, Biopolymers.